Intensive glucose control and cardiovascular disease in type 2 diabetes - Should we change the recommended target for glycated hemoglobin? Commentary to ACCORD and ADVANCE trials

Peter Gæede*

*Corresponding author for this work

    Research output: Contribution to journalEditorialResearchpeer-review

    Original languageEnglish
    Pages (from-to)619-621
    Number of pages3
    JournalPolskie Archiwum Medycyny Wewnetrznej
    Volume118
    Issue number11
    Publication statusPublished - 1 Jan 2008

    Cite this